Delivery Order SPE2DB22D3501-SPE2DB24FTR67

Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $3,544.70. Under this order, the contractor will supply 1,000 vials of the pharmaceutical Remifentanil at 1 mg per vial to DLA for use in military treatment programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 19, 2023. No set-aside designation was applied to this order, which...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $1,516.94. The order is for 4563132877 units of Remifentanil 1 mg vials to be delivered by December 19, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen Drug...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,324.70 from the Defense Logistics Agency Troop Support Medical to supply 2 mg vials of the pharmaceutical remifentanil. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all work to be completed by December 7, 2023. As a prime contractor and subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp routinely provides pharmaceuticals and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil. The $1,063.41 firm fixed price delivery order contract has an ultimate completion date of September 10, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract to supply this critical care medication to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.20 firm fixed-price delivery order is for the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REMIFENTANIL 1 MG VIALS. The contract has a completion date of January 4, 2024 and a potential value of $9,321.34. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal awards from the Defense Logistics Agency to...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $3,612.50 to provide 4561740719 units of the drug remifentanil hydrochloride in 1 mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned to fulfill this small order for...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication. The fixed-price delivery order has a ceiling value of $3,632.56 and a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,022.40 firm-fixed-price contract is for the supply of 2 mg vials of the drug remifentanil, a potent opioid analgesic. The award has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTR67
    Delivery Order

Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical prime vendor program. Valued at $5,671.52, this order is for the supply of 4562937628 units of Remifentanil 1 mg vials to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 30, 2023. No set-aside designation was applied to this award to fulfill DLA's requirements for specialty pharmaceuticals and critical care medical products.

Generated 2/28/24, 9:06 AM